The journal retracts the article “Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding the presence of image irregularities with a figure presented within this publication [1].
Adhering to our complaints procedure, an investigation was conducted by the Editorial Office and Editorial Board, which confirmed a range of inappropriate image modifications to panels presented in Figure 6. While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the above-mentioned concerns, nor provide appropriate raw material for Editorial Board evaluation. As a result, the Editorial Board has lost confidence in the integrity of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Pharmaceutics.
The authors agree to this retraction.
Reference
- Elsherif, N.I.; Al-Mahallawi, A.M.; Abdelkhalek, A.A.; Shamma, R.N. RETRACTED: Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment. Pharmaceutics 2021, 13, 700. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).